Literature DB >> 25458567

Searching human brain for mechanisms of psychiatric disorders. Implications for studies on schizophrenia.

Sabina Berretta1, Stephan Heckers2, Francine M Benes3.   

Abstract

In the past 25years, research on the human brain has been providing a clear path toward understanding the pathophysiology of psychiatric illnesses. The successes that have been accrued are matched by significant difficulties identifying and controlling a large number of potential confounding variables. By systematically and effectively accounting for unwanted variance in data from imaging and postmortem human brain studies, meaningful and reliable information regarding the pathophysiology of human brain disorders can be obtained. This perspective paper focuses on postmortem investigations to discuss some of the most challenging sources of variance, including diagnosis, comorbidity, substance abuse and pharmacological treatment, which confound investigations of the human brain.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Comorbidity; Confounding factors; Human postmortem; In vivo imaging; Psychiatric disorders

Mesh:

Year:  2014        PMID: 25458567      PMCID: PMC4427537          DOI: 10.1016/j.schres.2014.10.019

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  107 in total

Review 1.  Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5.

Authors:  Deanna M Barch; Juan Bustillo; Wolfgang Gaebel; Raquel Gur; Stephan Heckers; Dolores Malaspina; Michael J Owen; Susan Schultz; Rajiv Tandon; Ming Tsuang; Jim Van Os; William Carpenter
Journal:  Schizophr Res       Date:  2013-05-22       Impact factor: 4.939

2.  Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia.

Authors:  J K Millar; S Christie; S Anderson; D Lawson; D Hsiao-Wei Loh; R S Devon; B Arveiler; W J Muir; D H Blackwood; D J Porteous
Journal:  Mol Psychiatry       Date:  2001-03       Impact factor: 15.992

3.  Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Kevin P Conway; Wilson Compton; Frederick S Stinson; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

4.  Canonical TGF-beta signaling is required for the balance of excitatory/inhibitory transmission within the hippocampus and prepulse inhibition of acoustic startle.

Authors:  Mu Sun; Jonathan C Gewirtz; Lisa Bofenkamp; Robert J Wickham; Hong Ge; Michael B O'Connor
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

5.  Chromosomal location and genomic structure of the human translin-associated factor X gene (TRAX; TSNAX) revealed by intergenic splicing to DISC1, a gene disrupted by a translocation segregating with schizophrenia.

Authors:  J K Millar; S Christie; C A Semple; D J Porteous
Journal:  Genomics       Date:  2000-07-01       Impact factor: 5.736

Review 6.  Genetic and environmental influences on psychiatric comorbidity: a systematic review.

Authors:  M Cerdá; A Sagdeo; J Johnson; S Galea
Journal:  J Affect Disord       Date:  2009-12-11       Impact factor: 4.839

Review 7.  GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; David A Lewis
Journal:  Schizophr Bull       Date:  2008-06-26       Impact factor: 9.306

Review 8.  Comorbid anxiety in patients with psychosis.

Authors:  Mojca Zvezdana Dernovsek; Lilijana Sprah
Journal:  Psychiatr Danub       Date:  2009-09       Impact factor: 1.063

9.  GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls.

Authors:  S Akbarian; M M Huntsman; J J Kim; A Tafazzoli; S G Potkin; W E Bunney; E G Jones
Journal:  Cereb Cortex       Date:  1995 Nov-Dec       Impact factor: 5.357

Review 10.  Anxiety comorbidity in schizophrenia.

Authors:  Raphael J Braga; Graham P Reynolds; Samuel G Siris
Journal:  Psychiatry Res       Date:  2013-08-07       Impact factor: 3.222

View more
  4 in total

1.  White Matter in Schizophrenia Treatment Resistance.

Authors:  Peter Kochunov; Junchao Huang; Song Chen; Yanli Li; Shuping Tan; Fengmei Fan; Wei Feng; Yunhui Wang; Laura M Rowland; Anya Savransky; Xiaoming Du; Joshua Chiappelli; Shuo Chen; Neda Jahanshad; Paul M Thompson; Meghann C Ryan; Bhim Adhikari; Hemalatha Sampath; Yimin Cui; Zhiren Wang; Fude Yang; Yunlong Tan; L Elliot Hong
Journal:  Am J Psychiatry       Date:  2019-07-29       Impact factor: 18.112

2.  Perfusion fixation in brain banking: a systematic review.

Authors:  Whitney C McFadden; Hadley Walsh; Felix Richter; Céline Soudant; Clare H Bryce; Patrick R Hof; Mary Fowkes; John F Crary; Andrew T McKenzie
Journal:  Acta Neuropathol Commun       Date:  2019-09-05       Impact factor: 7.801

3.  Expression of HDAC2 but Not HDAC1 Transcript Is Reduced in Dorsolateral Prefrontal Cortex of Patients with Schizophrenia.

Authors:  Frederick A Schroeder; Tonya M Gilbert; Ningping Feng; Brendan D Taillon; Nora D Volkow; Robert B Innis; Jacob M Hooker; Barbara K Lipska
Journal:  ACS Chem Neurosci       Date:  2016-12-13       Impact factor: 4.418

4.  A glycomics and proteomics study of aging and Parkinson's disease in human brain.

Authors:  Rekha Raghunathan; John D Hogan; Adam Labadorf; Richard H Myers; Joseph Zaia
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.